Per Wikipedia:  “Human papillomavirus infection is an infection by human papillomavirus (HPV). Most HPV infections cause no symptoms and resolve spontaneously. In some people, an HPV infection persists and results in warts or precancerous lesions. The precancerous lesions increase the risk of cancer of the cervix, vulva, vagina, penis, anus, mouth, or throat. Nearly all cervical cancer is due to HPV with two types, HPV16 and HPV18, accounting for 70% of cases. Between 60% and 90% of the other cancers mentioned above are also linked to HPV. HPV6 and HPV11 are common causes of genital warts and laryngeal papillomatosis.

“An HPV infection is caused by human papillomavirus, a DNA virus from the papillomavirus family, of which over 170 types are known. More than 40 types are transmitted through sexual contact and infect the anus and genitals. Risk factors for persistent HPV infections include early age of first sexual intercourse, multiple partners, smoking, and poor immune function. HPV is typically spread by sustained direct skin-to-skin contact, with vaginal and anal sex being the most common methods. Occasionally, it can spread from a mother to her baby during pregnancy. It does not appear to spread via common items like toilet seats. People can become infected with more than one type of HPV. HPV affects only humans.”

The HPV vaccine protects against either 4 or 9 strains of HPV, including two that account for approximately 70% of all cases of cervical cancer.  According to the Association of Reproductive Health Professionals, the HPV vaccine is effective for approximately six years.

Vaccine Statistics

When debating informed consent, it is important that people calculate the risk versus the reward for all options.  Here are some facts, according to VAERS and the CDC.

  • Current rates of cervical cancer in the US are approximately 13,240 per year with a mortality rate of 1 in 42,000 women.
  • Since 2006, there have been 76 deaths reported to VAERS associated with the HPV vaccine
  • Since 2006, there have been 35,618 adverse events reported to VAERS

 Since 2006, there have been an average of 3.8 million live births in the US annually.  Approximately 49% of the population are vaccinated at three doses per series.  This leaves the odds of death from the HPV vaccine at approximately 1 in 880,000.  If the FDA’s assessment of reporting compliance is correct (<1%), this may be as high as 1 in 8800, a five-fold increase over the risk posed by cervical cancer.  The problem with this calculation, however, is that we simply do not know the true number of deaths attributable to the HPV vaccine due to our faulty reporting system.  Other statistics (based on estimated numbers of doses administered per the above calculation) reported since 2000 (rate reported/rate possible per FDA) per dose:

  • 542 immediately life threatening (1 in 125,000/1 in 1250)
  • 884 permanent disabilities (1 in 76,000/1 in 760)
  • 1769 hospitalizations or extensions of hospitalizations (1 in 37,000/1 in 370)
  • 11,094 emergency room or office visits related to complications (1 in 6000/1 in 60)

Some of the possible rates per the FDA are too chilling to want to believe, but in this case there is evidence that supports the case that the risks may be even greater.  In a study of girls vaccinated against HPV in Alberta, nearly 10% had an ED visit within 42 days of immunization.  Of those girls, nearly 25% were hospitalized (2.4% of those vaccinated).  In the US, a rationale that supports more significant underreporting of adverse events than other vaccines is the nature of the adverse events specific to this vaccine:  many more common AEs are small fiber neuropathies and dysautonomias such as POTS and complex regional pain syndrome which could result in ER visits without being associated by healthcare practitioners as being linked to vaccination.  These adverse events have been studied at greater length in Japan, and after a study demonstrated a potential link between the HPV vaccine and neurological dysfunction, the vaccine was no longer recommended by the government.

Vaccine Safety

Vaccine Typepeptide antigen/fully immune

Pregnancy ClassC

This section will reference the product insert for Gardasil as provided by the FDA.  The Gardasil vaccine uses high levels of aluminum adjuvants, and the Gardasil 9 vaccine uses extremely high amounts.

Contraindications (do not vaccinate):

  • Allergy or sensitivity to yeast or any other component of the vaccine

Adverse Events (as reported by the manufacturer):

  • Syncope (high risk), anaphylaxis, headache, fever, nausea, dizziness, injection site pain/swelling/erythema/pruritis/bruising, afebrile seizure, headache, pyrexia, oropharyngeal pain, diarrhea, nasopharyngitis, upper respiratory tract infection, upper abdominal pain, myalgia, vomiting, gastroenteritis, appendicitis, pelvic inflammatory disease, urinary tract infection, pneumonia, pyelonephritis, pulmonary embolism, bronchospasm, asthma, deep vein thrombosis, arthralgia, arthritis, arthropathy, autoimmune thyroiditis, celiac disease, diabetes mellitus, erythema nodosum, hyperthyroidism, hypothyroidism, inflammatory bowel disease, multiple sclerosis, nephritis, optic neuritis, pigmentation disorder, psoriasis, Reynaud’s phenomenon, rheumatoid arthritis, scleroderma, Stevens-Johnson syndrome, lupus, uveitis, alopecia areata, ankylosing spondylitis, autoimmune thrombocytopenia, myocarditis, proteinuria, psoriasis, vitiligo, autoimmune hemolytic anemia, idiopathic thrombocytopenic purpura, lymphadenopathy, pancreatitis, asthenia, chills, fatigue, malaise, myalgia, acute disseminated encephalomyelitis, Guillain-Barré syndrome, motor neuron disease, paralysis, transverse myelitis, cellulitis, and death


  • Lawsuit against Merck for fraud and vaccine injuries – “Merck’s own data show that the chances of getting an autoimmune disease from this vaccine are 1000 times the risk of dying from cervical cancer.” – “Merck’s own data showed that administering the Gardasil vaccine to girls who had previous exposure to HPV actually raised their risk of developing precancerous lesions (or worse) by almost 45%.”

Scientific studies

Editor’s Opinion

Cervical cancer is slow moving and has a low fatality rate.  On the other hand, longitudinal reports demonstrating that nearly 10% of those administered the HPV vaccine wind up in the ER are worrisome.  Furthermore, the concept of giving a short-lived vaccine to children ages 9-11 and telling them it will protect them from the consequences of a sexually transmitted disease, only to have protection wear off just as they are reaching the statistical period when they will become sexually active is unbelievably insane.  Given overwhelming evidence that the clinical trials for the HPV vaccine were fraudulent, and early evidence that the risk of death from the vaccine may be as high as five times greater than that of the disease it’s intended to prevent, we believe that the risks from this vaccine outweigh the benefits and do not recommend that any child be administered this vaccine.